Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Subjects: Abaloparatide; Anabolic treatment; Fragility fracture risk
-
Source:
Veronese , N , Briot , K , Guañabens , N , Albergaria , B H , Alokail , M , Al-Daghri , N , Bemden , A B , Bruyère , O , Burlet , N , Cooper , C , Curtis , E M , Ebeling , P R , Halbout , P , Hesse
-
تفاصيل العنوان
Subjects: Bone Density Conservation Agents/therapeutic use; Bone Diseases/drug therapy; Bone Neoplasms
-
Source:
Lund , T , Gundesen , M T , Juul Vangsted , A , Helleberg , C , Haukås , E , Silkjær , T , Asmussen , J T , Manuela Teodorescu , E , Amdi Jensen , B , Schmidt Slørdahl , T , Nahi , H , Waage , A ,
-
تفاصيل العنوان
Subjects: Aged; Bone Density Conservation Agents/therapeutic use; Decision Making
-
Source:
Bullock , L , Manning , F , Hawarden , A , Fleming , J , Leyland , S , Clark , E M , Thomas , S , Gidlow , C , Iglesias-Urrutia , C P , Protheroe , J , Lefroy , J , Ryan , S , O'Neill , T W , Mallen ,
-
تفاصيل العنوان
Subjects: Humans; Female; Alendronate/therapeutic use
-
Source:
Pedersen , A B , Risbo , N , Kafatos , G , Neasham , D , O'Kelly , J & Ehrenstein , V 2023 , ' Utilization patterns and factors associated with persistence of new users of anti-osteoporosis treatment
تفاصيل العنوان
Subjects: Bone Density Conservation Agents/therapeutic use; China/epidemiology; Cost-Benefit Analysis
-
Source:
Li , N , Si , L , Boonen , A , van den Bergh , J P & Hiligsmann , M 2022 , ' A model-based cost-effectiveness analysis of fracture liaison services in China ' , Archives of Osteoporosis , vol. 17 ,
-
تفاصيل العنوان
